Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Veeva Systems (NYSE:VEEV) and the best and worst performers in the vertical software industry.
Q4 Rundown: Astrana Health (NASDAQ:ASTH) Vs Other Healthcare Technology for Providers Stocks
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers.
3 Reasons to Avoid ACHC and 1 Stock to Buy Instead
What a brutal six months it’s been for Acadia Healthcare. The stock has dropped 56.9% and now trades at $24.75, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons to Sell DE and 1 Stock to Buy Instead
Deere currently trades at $461.71 and has been a dream stock for shareholders. It’s returned 255% since April 2020, nearly tripling the S&P 500’s 91.4% gain. The company has also beaten the index over the past six months as its stock price is up 12.8%.
3 Reasons to Sell ODFL and 1 Stock to Buy Instead
Shareholders of Old Dominion Freight Line would probably like to forget the past six months even happened. The stock dropped 25.8% and now trades at $151.05. This may have investors wondering how to approach the situation.
3 Reasons to Sell CSV and 1 Stock to Buy Instead
Since April 2020, the S&P 500 has delivered a total return of 91.4%. But one standout stock has nearly doubled the market - over the past five years, Carriage Services has surged 170% to $37.31 per share. Its momentum hasn’t stopped as it’s also gained 18.6% in the last six months, beating the S&P by 26.9%.
3 Reasons to Avoid CBRE and 1 Stock to Buy Instead
CBRE currently trades at $118.95 per share and has shown little upside over the past six months, posting a small loss of 4.4%.
3 Reasons J is Risky and 1 Stock to Buy Instead
Over the last six months, Jacobs Solutions shares have sunk to $117.99, producing a disappointing 16.5% loss - worse than the S&P 500’s 8.3% drop. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
3 Reasons PLUS is Risky and 1 Stock to Buy Instead
ePlus has gotten torched over the last six months - since October 2024, its stock price has dropped 41.2% to $58.24 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Vertical Software Stocks Q4 Results: Benchmarking Q2 Holdings (NYSE:QTWO)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the vertical software industry, including Q2 Holdings (NYSE:QTWO) and its peers.